-
AHF denies BMS sales reprepresentatives access to healthcare centersToday AIDS Healthcare Foundation (AHF) announced that it has banned pharmaceutical sales representatives from Bristol-Myers Squibb (BMS) from calling on AHF's medical providers and staff in its sixtee2010/7/28
-
Novartis launches new OTC children's liquid acetaminophen productNovartis announces the introduction of Triaminic™ Fever Reducer Pain Reliever, the only branded over-the-counter children's liquid acetaminophen product currently available nationwide in the US.2010/7/28
-
FDA approves Perrigo's OTC Cetirizine Cherry SyrupPerrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry S2010/7/27
-
Tibotec submits NDA for TMC278 anti-HIV compound to FDATibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reve2010/7/27
-
China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal SuppositoriesChina Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that2010/7/26
-
First generic version of Lovenox receives FDA approval for DVTThe U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a potentiall2010/7/26
-
2010 H1 report: Jiangsu Kanion Pharmaceutical (600557.SH)BEIJING, Jul 25, 2010 (Xinhua via COMTEX) -- The following is a table showing the main business indicators for the first half of 2010 of Shanghai-listed Jiangsu Kanion Pharmaceutical Co. Ltd. (600552010/7/26
-
Caraco Pharmaceutical Laboratories begins marketing bupropion hydrochloride extended release tabletsCaraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administrati2010/7/23
-
Voreloxin and Cytarabine Combination Gets EU PatentThe European Patent Office (EPO) has issued a European patent covering combinations of Sunesis Pharmaceuticals' drug candidate voreloxin with cytarabine. Cytarabine is the standard-of-care treatment2010/7/23
-
FDA Approves Bacterial Vaginosis Drug TrialStarpharma Holdings has received US Food and Drug Administration (FDA) approval to begin a Phase II study to investigate VivaGel for the treatment of bacterial vaginosis. More than 130 women are enr2010/7/23